Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
4h
Biotech Stock Roundup: VNDA, JAZZ Up on Updates, NVAX Suffers Setback & More
Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.
18h
Exelixis: Navigating Patent Challenges and Future Growth Prospects with a Hold Rating
Leerink Partners analyst Andrew Berens has maintained their neutral stance on EXEL stock, giving a Hold rating today. Andrew Berens has given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Hamas leader Sinwar killed
Preliminary cause of death
Panel calls for 'reform'
Charged with theft
Fox News interview
100-yr-old capsule unveiled
NH justice indicted
Microscopic world photos
Italy expands surrogacy ban
Teacher re-enacted murder
DA aims to revive charges
FDA halts Novavax trial
Abortion group sues Florida
Constitution copy auction
US strikes Houthi targets
To settle US bribery probe
Sentenced for cartel bribery
Allows EPA emissions rule
More loan forgiveness
Meta confirms layoffs
$425M military aid for UKR
Antisemitic billboard hack
AL voter roll purge blocked
May help with addiction too
21K+ SUVs recalled
GA election rules blocked
US retail sales climb
Related topics
Exelixis
MSN
Feedback